{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:10:20Z","timestamp":1790071820993,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01455-4","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:40:32Z","timestamp":1790070032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The deubiquitinase USP5 mediates anti-PD-L1 resistance in breast cancer by stabilizing FOXM1 to upregulate Nectin2"],"prefix":"10.1007","volume":"39","author":[{"given":"Guangyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"1","key":"1455_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12943-025-02422-7","volume":"24","author":"X Peng","year":"2025","unstructured":"Peng X, Wang Y, Yu Z, et al. Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer. Mol Cancer. 2025;24(1):217.","journal-title":"Mol Cancer"},{"key":"1455_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-025-01793-5","author":"Y Shin","year":"2025","unstructured":"Shin Y, Shin K, Lee S, Son Y, Rhee I. Immune checkpoint inhibition in breast cancer: targeting PD-1\/PD-L1 pathway for therapeutic advances. Breast Cancer (Auckl). 2025. https:\/\/doi.org\/10.1007\/s12282-025-01793-5.","journal-title":"Breast Cancer (Auckl)"},{"issue":"1","key":"1455_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12935-025-03769-z","volume":"25","author":"H Li","year":"2025","unstructured":"Li H, Chang Y, Jin T, Zhang M. Progress of PD-1\/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer. Cancer Cell Int. 2025;25(1):139.","journal-title":"Cancer Cell Int"},{"key":"1455_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010104","author":"X Chen","year":"2022","unstructured":"Chen X, Feng L, Huang Y, Wu Y, Xie N. Mechanisms and strategies to overcome PD-1\/PD-L1 blockade resistance in triple-negative breast cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers15010104.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1455_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1631\/jzus.B2200195","volume":"23","author":"Z Gao","year":"2022","unstructured":"Gao Z, Ling X, Shi C, Wang Y, Lin A. Tumor immune checkpoints and their associated inhibitors. J Zhejiang Univ Sci B. 2022;23(10):823\u201343.","journal-title":"J Zhejiang Univ Sci B"},{"key":"1455_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073200","author":"W Roma\u0144czyk","year":"2025","unstructured":"Roma\u0144czyk W, Pryczynicz A. The significance of nectin family proteins in various cancerogenous processes. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26073200.","journal-title":"Int J Mol Sci"},{"key":"1455_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1552151","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Zhang Y, Zhu Y, et al. Functional insights into immunoglobulin superfamily proteins in invertebrate neurobiology and immunity. Front Immunol. 2025;16:1552151.","journal-title":"Front Immunol"},{"issue":"1","key":"1455_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13046-024-03178-6","volume":"43","author":"H Luo","year":"2024","unstructured":"Luo H, Ikenaga N, Nakata K, et al. Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2024;43(1):258.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1455_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/eji.201847848","volume":"49","author":"R Molfetta","year":"2019","unstructured":"Molfetta R, Milito ND, Zitti B, et al. The Ubiquitin-proteasome pathway regulates Nectin2\/CD112 expression and impairs NK cell recognition and killing. Eur J Immunol. 2019;49(6):873\u201383.","journal-title":"Eur J Immunol"},{"key":"1455_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1476-4598-12-60","volume":"12","author":"T Oshima","year":"2013","unstructured":"Oshima T, Sato S, Kato J, et al. Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers. Mol Cancer. 2013;12:60.","journal-title":"Mol Cancer"},{"key":"1455_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216985","volume":"595","author":"DJ Agorku","year":"2024","unstructured":"Agorku DJ, Bosio A, Alves F, Str\u00f6bel P, Hardt O. Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling. Cancer Lett. 2024;595:216985.","journal-title":"Cancer Lett"},{"issue":"1","key":"1455_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13058-023-01675-8","volume":"25","author":"BS Katzenellenbogen","year":"2023","unstructured":"Katzenellenbogen BS, Guillen VS, Katzenellenbogen JA. Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer. Breast Cancer Res. 2023;25(1):76.","journal-title":"Breast Cancer Res"},{"key":"1455_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223823","author":"S Dilmac","year":"2024","unstructured":"Dilmac S, Hamurcu Z, Ozpolat B. Therapeutic landscape of FOXM1 in triple-negative breast cancer and aggressive solid cancers. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16223823.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1455_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167673","volume":"1871","author":"X Ding","year":"2025","unstructured":"Ding X, Shi J, Lei Z, et al. FOXM1 promotes malignant biological behavior and metabolic reprogramming by targeting SPINK1 in hepatocellular carcinoma and affecting the p53 pathway. Biochim Biophys Acta Mol Basis Dis. 2025;1871(3):167673.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1455_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-025-01755-w","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ma R, Yang Q, et al. Macrophage polarization-based analysis of the role of the FOXM1\/KIF20A axis in breast cancer metastasis. Cell Biochem Biophys. 2025. https:\/\/doi.org\/10.1007\/s12013-025-01755-w.","journal-title":"Cell Biochem Biophys"},{"key":"1455_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05322-y","author":"S Du","year":"2025","unstructured":"Du S, Li P, Liu Y, et al. FOXM1 upregulation, promotes immune escape in gastric cancer through activation of Notch signaling pathway. Mol Cell Biochem. 2025. https:\/\/doi.org\/10.1007\/s11010-025-05322-y.","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"1455_CR17","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/1878-0261.70033","volume":"19","author":"D Kim","year":"2025","unstructured":"Kim D, Nam HJ, Baek SH. Ubiquitination of transcription factors in cancer: unveiling therapeutic potential. Mol Oncol. 2025;19(8):2174\u201395.","journal-title":"Mol Oncol"},{"issue":"6","key":"1455_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3892\/ol.2024.14705","volume":"28","author":"QK Wan","year":"2024","unstructured":"Wan QK, Li TT, Liu BB, He B. USP5 promotes tumor progression by stabilizing SLUG in bladder cancer. Oncol Lett. 2024;28(6):572.","journal-title":"Oncol Lett"},{"key":"1455_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101186","volume":"66","author":"K Ma","year":"2025","unstructured":"Ma K, Li Q, Zhang Y, et al. CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2\u03b1 deubiquitination. Neoplasia. 2025;66:101186.","journal-title":"Neoplasia"},{"issue":"2","key":"1455_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/0115665240278762240202103722","volume":"25","author":"J Song","year":"2025","unstructured":"Song J, Liu L, Wang F, Bao D. Targeting ubiquitin-specific protease 5 overcomes chemoresistance via negatively regulating p53 in gastric cancer. Curr Mol Med. 2025;25(2):211\u201321.","journal-title":"Curr Mol Med"},{"issue":"21","key":"1455_CR21","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1002\/cam4.3410","volume":"9","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wu X. Study and analysis of antitumor resistance mechanism of PD1\/PD-L1 immune checkpoint blocker. Cancer Med. 2020;9(21):8086\u2013121.","journal-title":"Cancer Med"},{"key":"1455_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104557","volume":"157","author":"F Ning","year":"2020","unstructured":"Ning F, Xin H, Liu J, et al. Structure and function of USP5: insight into physiological and pathophysiological roles. Pharmacol Res. 2020;157:104557.","journal-title":"Pharmacol Res"},{"key":"1455_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156105","volume":"273","author":"J Zhou","year":"2025","unstructured":"Zhou J, Cai X, Ma K, et al. Deubiquitinase USP5 regulates cancer progression and radiosensitivity by stabilizing HOXA10 in non-small cell lung cancer. Pathol Res Pract. 2025;273:156105.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"1455_CR24","doi-asserted-by":"publisher","first-page":"C833","DOI":"10.1152\/ajpcell.00249.2023","volume":"325","author":"Q Wang","year":"2023","unstructured":"Wang Q, Chen F, Yang N, et al. DEPDC1B-mediated USP5 deubiquitination of \u03b2-catenin promotes breast cancer metastasis by activating the wnt\/\u03b2-catenin pathway. Am J Physiol Cell Physiol. 2023;325(4):C833-c848.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"Pt 1","key":"1455_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.141378","volume":"306","author":"Z Yang","year":"2025","unstructured":"Yang Z, Yu Z, Teng J, et al. PDK1-mediated phosphorylation of USP5 modulates NF-\u03baB signalling to enhance osteosarcoma growth. Int J Biol Macromol. 2025;306(Pt 1):141378.","journal-title":"Int J Biol Macromol"},{"issue":"15","key":"1455_CR26","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.7150\/ijbs.119868","volume":"21","author":"H Feng","year":"2025","unstructured":"Feng H, Wang Q, Li L, et al. \u03b1-hederin targets USP5 to inhibit colorectal tumorigenesis by disrupting STAT3 deubiquitination. Int J Biol Sci. 2025;21(15):6697\u2013722.","journal-title":"Int J Biol Sci"},{"key":"1455_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146792","author":"E Biltekin","year":"2025","unstructured":"Biltekin E, Kahraman N, Gul OA, et al. Inhibition of FOXM1 leads to suppression of cell proliferation, migration, and invasion through AXL\/eEF2 kinase signaling and induces apoptosis and ferroptosis in GBM cells. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26146792.","journal-title":"Int J Mol Sci"},{"key":"1455_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040756","author":"N Merjaneh","year":"2024","unstructured":"Merjaneh N, Hajjar M, Lan Y-W, Kalinichenko VV, Kalin TV. The promise of combination therapies with FOXM1 inhibitors for cancer treatment. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16040756.","journal-title":"Cancers (Basel)"},{"issue":"29","key":"1455_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202702","volume":"9","author":"H Madhi","year":"2022","unstructured":"Madhi H, Lee JS, Choi YE, et al. FOXM1 inhibition enhances the therapeutic outcome of lung cancer immunotherapy by modulating PD-L1 expression and cell proliferation. Adv Sci (Weinh). 2022;9(29):e2202702.","journal-title":"Adv Sci (Weinh)"},{"key":"1455_CR30","doi-asserted-by":"publisher","DOI":"10.1266\/ggs.24-00079","author":"T Wang","year":"2025","unstructured":"Wang T, Zhang Y, Liu H, Wu J. FOXM1 derived from triple-negative breast cancer exosomes promotes cancer progression by activating IDO1 transcription in macrophages to suppress ferroptosis and induce M2 polarization of tumor-associated macrophages. Genes Genet Syst. 2025. https:\/\/doi.org\/10.1266\/ggs.24-00079.","journal-title":"Genes Genet Syst"},{"key":"1455_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186863","author":"MI Appadurai","year":"2025","unstructured":"Appadurai MI, Chaudhary S, Shah A, et al. ST6GalNAc-I regulates tumor cell sialylation via NECTIN2\/MUC5AC-mediated immunosuppression and angiogenesis in non-small cell lung cancer. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI186863.","journal-title":"J Clin Invest"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01455-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01455-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01455-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:40:32Z","timestamp":1790070032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01455-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01455-4","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all the enrolled participants. This study was carried out in accordance with the Declaration of Helsinki, after approval by the Second Affiliated Hospital of Harbin Medical University (YJSKY2025-186). All animal procedures were performed in accordance with the guidelines of the Ethics Committee of the Second Affiliated Hospital of Harbin Medical University and complied with ethical standards for animal experiments (YJSDW2024-238).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"144"}}